11 insiders reported 178 Form 4 transactions for Enliven Therapeutics, Inc. (ELVN) over the past 18 months (most recent 2026-08-19). Recent activity: Hohl Benjamin (CHIEF FINANCIAL OFFICER) Sell 4,630 shares, Collins Helen Louise (CHIEF MEDICAL OFFICER) Buy 5,000 shares, Collins Helen Louise (CHIEF MEDICAL OFFICER) Sell 3,900 shares, Hohl Benjamin (CHIEF FINANCIAL OFFICER) Sell 1,388 shares, Collins Helen Louise (CHIEF MEDICAL OFFICER) Sell 1,100 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 4,630 | $270,168 |
| 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 3,900 | $227,650 |
| 2026-08-19 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,388 | $82,383 |
| 2026-08-19 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 1,100 | $65,281 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 87,373 | $216,685 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 27,567 | $696,894 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 23,364 | $346,955 |
| 2026-08-06 | Derynck Mika K | Director | Buy | 20,491 | $460,433 |
| 2026-08-06 | Derynck Mika K | Director | Sell | 158,795 | $9.6M |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 231 | $11,563 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Buy | 1,072 | $2,659 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Buy | 5,000 | $12,400 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 324 | $16,191 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 459 | $23,660 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 369 | $18,997 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 2,063 | $108,085 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 2,564 | $134,143 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 2,184 | $116,669 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 2,638 | $140,823 |
| 2026-07-21 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 63 | $3,397 |
| 2026-07-21 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 123 | $6,626 |
| 2026-07-08 | Kunkel Lori Anne | Director | Sell | 4,111 | $205,482 |
| 2026-07-08 | Kunkel Lori Anne | Director | Sell | 5,889 | $299,421 |
| 2026-06-24 | ORBIMED ADVISORS LLC | 10% Owner | Sell | 24,846 | $1.1M |
Source: SEC Form 4 filings · as of 2026-08-19